After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

Conexeu Sciences (CNXU) announced a preclinical development partnership with the Wake Forest Institute for Regenerative Medicine (WFIRM) to evaluate its proprietary B.R.E.A.S.T. 3D-printed tissue matrix. The program will leverage WFIRM’s Integrated Tissue-Organ Printing System (iTOPS) to assess durability, host tissue integration, and resorbability of the matrix, aiming to generate data for future clinical investigation.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.